INVESTORS & MEDIA
Corporate Governance
| Date | Name | Title | Filing | Type | Shares Traded | Price | Total Held |
|---|---|---|---|---|---|---|---|
| Mar 06, 2014 |
Director, President Regeneron Laboratori
|
Director, President Regeneron Laboratori | Form 4 | Bona fide gift | 23,367 | -- | -- |
| Mar 06, 2014 |
Director, President Regeneron Laboratori
|
Director, President Regeneron Laboratori | Form 4 | Bona fide gift | 23,367 | -- | 23,367 |
| Feb 13, 2014 |
Director, President Regeneron Laboratori
|
Director, President Regeneron Laboratori | Form 4 | Bona fide gift | 568,343 | -- | 500,000 |
| Feb 13, 2014 |
Director, President Regeneron Laboratori
|
Director, President Regeneron Laboratori | Form 4 | Bona fide gift | 568,343 | -- | 568,343 |
| Feb 13, 2014 |
Director, President Regeneron Laboratori
|
Director, President Regeneron Laboratori | Form 4 | Other acquisition or disposition | -- | -- | 5,623 |
| Feb 11, 2014 |
Director, President Regeneron Laboratori
|
Director, President Regeneron Laboratori | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 189,463 | -- | -- |
| Feb 11, 2014 |
Director, President Regeneron Laboratori
|
Director, President Regeneron Laboratori | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 5,720 | -- | 5,720 |
| Dec 20, 2013 |
Director, President Regeneron Laboratori
|
Director, President Regeneron Laboratori | Form 4 | Other acquisition or disposition | -- | -- | 5,591 |
| Dec 19, 2013 |
Director, President Regeneron Laboratori
|
Director, President Regeneron Laboratori | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 4,705 | -- | -- |
| Dec 17, 2013 |
Director, Pres Regeneron Labs
|
Director, Pres Regeneron Labs | Form 4 | Other acquisition or disposition | -- | -- | 5,591 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.